23 research outputs found

    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

    Get PDF
    Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≄ II, EF ≀35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure < 100 mmHg (n = 1127), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

    Assessment of the light intensity of otoscopes utilized in teaching hospitals

    Get PDF
    ABSTRACT INTRODUCTION: To attain an accurate otoscopic diagnosis, a functioning device with adequate capacity must be used. OBJECTIVE: Evaluate the light intensity of otoscopes, comparing it utilizing the batteries present at the moment of calibration and after new batteries were supplied. METHODS: Cross-sectional study of a historical cohort, which assessed 38 otoscopes, measuring the light intensity with the batteries present at the moment of assessment compared to the intensity with new batteries, as well as charge of the test batteries and the new batteries. RESULTS: The mean of the sum of new batteries' charge was 3.19 V, and of the test batteries was 2.70 V, representing a decrease of 18.02% in charge. The mean luminosity with the new batteries was 366.89 lumens, whereas in the test batteries it was 188.32 lumens, representing a decrease of 83.75% in the light intensity. Student's t-test was applied for data comparison, showing a statistical difference between the light intensity with the original batteries and the new batteries (p = 0.0001; CI = 0.95). CONCLUSION: There was a statistically significant difference between the proportions of light intensity in the otoscopes. A small variation in battery charge results in a great variation in light

    Prevention of the Evolution of Workers' Hearing Loss from Noise-Induced Hearing Loss in Noisy Environments through a Hearing Conservation Program

    No full text
    Introduction Noise-induced hearing loss (NIHL) is a serious problem for workers and therefore for businesses. The hearing conservation program (HCP) is a set of coordinated measures to prevent the development or evolution of occupational hearing loss, which involves a continuous and dynamic process of implementation of hearing conservation routines through anticipation, recognition, evaluation, and subsequent control of the occurrence of existing environmental risks or of those thatmay exist in the workplace and lead to workers hearing damage. Objective The aim of this study was to evaluate the effectiveness of the HCP in preventing further hearing loss in workers with audiograms suggestive of NIHL. The audiometric tests and medical records of 28 furniture company workers exposed to noise were reviewed and monitored for 2 years. Methods This retrospective, cross-sectional study examined five audiometric tests in the medical records (on admission and every semester) of 28 workers in a furniture company (totaling 140 audiometric exams) following the introduction of the HCP. Results Data analysis showed no differences between the audiometric tests conducted on admission and those performed every semester. Conclusions The HCP implemented was effective in preventing the worsening of hearing loss in workers already with NIHL when exposed to occupational noise. Therefore, such a measure could be useful for the employment of workers with hearing loss in job sectors that have noise exposure

    Estudo da prevalĂȘncia de hipoacusia em indivĂ­duos com diabetes mellitus tipo 1 Hearing loss prevalence in patients with diabetes mellitus type 1

    Get PDF
    Diabetes mellitus (DM) Ă© uma doença crĂŽnica causada pela nĂŁo produção e uso inadequado de insulina. Enfermidade crĂŽnico-degenerativa. ComplicaçÔes crĂŽnicas do DM, no sistema auditivo, podem causar atrofia do gĂąnglio espiral, degeneração da bainha de mielina do VIII par craniano, diminuição de fibras nervosas na lĂąmina espiral ou espessamento das paredes capilares da estria vascular e das pequenas artĂ©rias. OBJETIVO: Verificar os limiares auditivos em indivĂ­duos portadores de DM tipo 1. MATERIAL E MÉTODOS: Estudo clĂ­nico envolvendo 60 indivĂ­duos, divididos em Grupo Estudo (GE) e Grupo Controle (GC), indivĂ­duos diabĂ©ticos e nĂŁo diabĂ©ticos. Realizada anamnese, exame fĂ­sico, otorrinolaringolĂłgico e exame audiomĂ©trico. RESULTADOS:Quanto aos limiares de audibilidade, no GE, houve diferença estatisticamente significante nas frequĂȘncias 250, 500, 10.000, 11.200, 12.500, 14.000 e 16.000 Hz em ambas as orelhas e mĂ©dias das orelhas. Na comparação dos GE e GC, houve diferença estatisticamente significativa com maior probabilidade de ocorrĂȘncia de hipoacusia em alguma frequĂȘncia independente da orelha testada no GE. CONCLUSÕES: Houve diferenças estatisticamente significativas nos achados audiolĂłgicos no GE quando comparado com GC, justificando avaliação audiolĂłgica completa em pacientes diabĂ©ticos tipo 1, incluindo audiometria de altas frequĂȘncias.<br>Diabetes mellitus (DM) is a chronic degenerative disease that impairs normal insulin production and use. DM chronic auditory complications may include spiral ganglion atrophy, degeneration of the vestibulocochlear nerve myelin sheath, reduction of the number of spiral lamina nerve fibers, and thickening of the capillary walls of the stria vascularis and small arteries. OBJECTIVE: This paper aims to verify the hearing thresholds of individuals with type 1 DM. MATERIALS AND METHODS: Sixty patients were enrolled in this trial and divided into case and control groups featuring diabetic and non-diabetic subjects respectively. All individuals were interviewed and underwent physical examination, ENT examination, and audiometric tests. RESULTS: Statistically significant difference was observed in hearing thresholds of case group subjects at 250, 500, 10,000, 11,200, 12,500, 14,000 and 16,000 Hz for both ears and ear average. Case group subjects had higher likelihood of having hypacusis at any frequency regardless of ear than controls. CONCLUSION: Statistically significant differences were seen in the audiological findings of case group subjects when compared to controls. Thorough audiological examination including high frequency audiometry is required for subjects with diabetes mellitus type 1

    Neurotological Findings at a Health Unit for Adults with Cervicalgia

    No full text
    Abstract Introduction The cervical spine is a flexible link between the sensory platform of the skull and torso. The fundamental principle of its operation is due to the balance between muscle strength and flexibility, and any dysfunction of this balance causes neck pain, known as cervicalgia. Objective The objective of this study is to analyze the most prevalent neurotological findings in adults with neck pain. Method A cross-sectional study in which 33 adults from 50 to 83 years of age with neck pain were evaluated and underwent the following procedures: anamnesis, as well as ENT, audiological, and vestibular exams. Results The most evident neurotological symptoms were dizziness (75.7%), tinnitus, neck cracking, tingling in the extremities, and auditory problems (36.3% for each). The most frequently reported clinical symptoms were related to cardiovascular (69.7%), endocrine-metabolic (48.5%), and rheumatic (30.3%) systems. In the audiological assessment, 30 subjects (91.0%) presented hearing impairment in at least one ear, with sensorineural impairment being the most prevalent (88.0%). In the vestibular assessment, there were alterations in 13 subjects (39.0%) found in the caloric test. There was a prevalence of alterations in the peripheral vestibular system with a predominance of irritative peripheral vestibular dysfunction. Conclusion Neurotological complaints were frequent in this population, verifying the importance of these tests in the dysfunctions of the cervical region or the craniocervical junction

    Måquina de perfusão versus armazenamento eståtico na preservação renal de doadores com morte encefålica: revisão sistemåtica e metanålise.

    No full text
    RESUMO Com a utilização crescente da mĂĄquina de perfusĂŁo no transplante renal, tem sido constatado que a isquemia dinĂąmica correlaciona-se Ă  melhora da preservação orgĂąnica. Nesse contexto, realizamos uma revisĂŁo sistemĂĄtica que procurou avaliar a eficĂĄcia do uso de mĂĄquina de perfusĂŁo portĂĄtil (LifePort Kidney Transporter MachineÂź), utilizada no Brasil, comparada ao armazenamento estĂĄtico, no que tange Ă  função retardada do transplante renal de doadores com morte encefĂĄlica. Foi efetuada pesquisa bibliogrĂĄfica, nas bases LILACS, MEDLINE via PubMed, Scopus, Clarivate Analytics, Cochrane Library, Embase, SciELO, alĂ©m de busca manual no Google acadĂȘmico. A revisĂŁo sistemĂĄtica, finalizada em abril 2017, foi constituĂ­da somente por ensaios clĂ­nicos randomizados. Para metanĂĄlise, foram avaliadas RazĂŁo de Risco e RazĂŁo de Chance. Foram identificados 86 documentos e selecionados, ao final, dois artigos com critĂ©rios de elegibilidade para metanĂĄlise, de grupos europeus e brasileiros. Nestes, 374 rins foram alocados para a mĂĄquina de perfusĂŁo, e igual nĂșmero para o armazenamento estĂĄtico. A função retardada do enxerto foi constatada em 84 e 110 pacientes, respectivamente. Na metanĂĄlise, foram obtidas uma RazĂŁo de Risco de 0,7568 (p=0,0151) e uma RazĂŁo de Chance de 0,6665 (p=0,0225), ambas com intervalo de confiança de 95%. A mĂĄquina de perfusĂŁo reduziu a incidĂȘncia de função retardada do enxerto de doadores com morte encefĂĄlica
    corecore